TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21612912

Group type: EXPERIMENTAL
Intervention: Psycho-oncological intervention in high-risk patients
Number of subjects: 131

Group type: COMPARATOR
Intervention: Observation group (control)
Number of subjects: 131
Study: 18712761

Group type: EXPERIMENTAL
Intervention: Long-term survivor model with bivariate random effects applied to leukemia patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term survivor model with bivariate random effects applied to carcinoma patients
Number of subjects: 0
Study: 21205873

Group type: EXPERIMENTAL
Intervention: Inhibition of Return (IOR) during visual search tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control locations (not specified)
Number of subjects: 0
Study: 16110714

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 300
Study: 11886009

Group type: EXPERIMENTAL
Intervention: EAP regimen (etoposide, adriamycin and cisplatin) followed by Machover schedule (fluorouracil and folinic acid)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control arm (no specific intervention mentioned)
Number of subjects: 274
Study: 9848504

Group type: EXPERIMENTAL
Intervention: NCEP Step I soy‐protein diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: NCEP Step I animal protein diet
Number of subjects: 26
Study: 7496915

Group type: EXPERIMENTAL
Intervention: Purified surface antigen vaccine (SAV)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Whole virus vaccine
Number of subjects: 38
Study: 2573098

Group type: EXPERIMENTAL
Intervention: Perazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluphenazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trifluoperazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0
Study: 1251319

Group type: EXPERIMENTAL
Intervention: Sepsis group (14 patients)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sepsis group (16 patients)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sepsis group (both groups)
Number of subjects: 30
Study: 30216239

Group type: EXPERIMENTAL
Intervention: RMSIT
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: RMET
Number of subjects: 36

Group type: COMPARATOR
Intervention: PLAT
Number of subjects: 36
Study: 30385541

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy plus TENMS
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional physical therapy alone (control group)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: TENMS
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 26136525

Group type: EXPERIMENTAL
Intervention: Cigarettes
Number of subjects: 123399

Group type: EXPERIMENTAL
Intervention: Cigars
Number of subjects: 123399

Group type: EXPERIMENTAL
Intervention: Chewing Tobacco
Number of subjects: 123399

Group type: EXPERIMENTAL
Intervention: Snuff
Number of subjects: 123399
Study: 24565934

Group type: EXPERIMENTAL
Intervention: GYNEFFIK(®) electro-stimulation sessions
Number of subjects: 95

Group type: COMPARATOR
Intervention: Usual care (no electro-stimulation)
Number of subjects: 95
Study: 22160629

Group type: EXPERIMENTAL
Intervention: Center-based exercise and lymphedema education intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Patient education
Number of subjects: 104
Study: 19077911

Group type: EXPERIMENTAL
Intervention: 0.1 mmoL/kg gadobenate dimeglumine (Gd-BOPTA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.2 mmoL/kg gadopentetate dimeglumine (Gd-DTPA)
Number of subjects: 40
Study: 17760868

Group type: EXPERIMENTAL
Intervention: 850 degrees C/0.5 hr
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 850 degrees C/1 hr
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 850 degrees C/3 hr
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 750 degrees C/6 hr
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 800 degrees C/6 hr
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 850 degrees C/6 hr
Number of subjects: 60
Study: 15376797

Group type: EXPERIMENTAL
Intervention: Famous faces rated as 'good'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Famous faces rated as 'evil'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants who liked the famous person
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants who disliked the famous person
Number of subjects: 0
Study: 11257395

Group type: EXPERIMENTAL
Intervention: Adjuvant active specific immunotherapy
Number of subjects: 0
Study: 9637643

Group type: EXPERIMENTAL
Intervention: Local-anesthetic-only group (5 ml 0.25% bupivacaine without catheter manipulation)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Catheter-manipulation group (5 ml 0.25% bupivacaine after withdrawing the catheter 1 cm)
Number of subjects: 78
Study: 9160564

Group type: EXPERIMENTAL
Intervention: L‐365,260 (30 mg four times daily for six weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (for six weeks)
Number of subjects: 38
Study: 2686478

Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg and Lorazepam 4 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiothixene 5 mg and Lorazepam 4 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg and Phenobarbital sodium 130 mg
Number of subjects: 0
Study: 5114822

Group type: EXPERIMENTAL
Intervention: Marihuana smoke administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo smoke administration
Number of subjects: 0
Study: 31701693

Group type: EXPERIMENTAL
Intervention: South Asian men with prediabetes and overweight or obesity
Number of subjects: 20
Study: 29197080

Group type: EXPERIMENTAL
Intervention: 10 ml boluses of bupivacaine 0.0625% + fentanyl 2 μg.ml‐1 at a 40 min interval
Number of subjects: 40
Study: 29037230

Group type: EXPERIMENTAL
Intervention: Multi-component intervention focusing on knowledge of health effects of SHS, attitudes towards SHS exposure, right to smoke-free living, and women empowerment against smoking for 6 months.
Number of subjects: 750

Group type: COMPARATOR
Intervention: Control group received no intervention.
Number of subjects: 750
Study: 26226215

Group type: EXPERIMENTAL
Intervention: High reversibility (HR) asthma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low reversibility (LR) asthma
Number of subjects: 0
Study: 24220504

Group type: EXPERIMENTAL
Intervention: Golden plaster administered externally for 2 weeks
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo plaster administered externally for 2 weeks
Number of subjects: 320
Study: 21911741

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20,000 IU vitamin D(3) twice weekly for 6 months)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo (identical-looking capsules)
Number of subjects: 108
Study: 18368834

Group type: EXPERIMENTAL
Intervention: Ondansetron as lingual tablets
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Ondansetron as syrup
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Ondansetron intravenously injected during induction to anesthesia
Number of subjects: 4

Group type: COMPARATOR
Intervention: No antiemetics (control group)
Number of subjects: 4
Study: 16809741

Group type: EXPERIMENTAL
Intervention: HRQL assessment in surgical oncology trials
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: HRQL assessment in surgical oncology trials with robust design
Number of subjects: 33
Study: 11820367

Group type: EXPERIMENTAL
Intervention: Nasal immunization with glucosyltransferase-enriched preparation (E-GTF)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Tonsillar immunization with glucosyltransferase-enriched preparation (E-GTF)
Number of subjects: 21
Study: 10638341

Group type: EXPERIMENTAL
Intervention: External nasal dilator strip (ENDS)
Number of subjects: 9
Study: 8674466

Group type: EXPERIMENTAL
Intervention: Haloperidol (HAL) administered orally at three fixed doses: 6 mg per day, 10 mg per day, and 15 mg per day for 2 weeks.
Number of subjects: 15
Study: 2105256

Group type: EXPERIMENTAL
Intervention: Enteral-tube feeding as the sole nutritional support (n = 16)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Isocaloric, isonitrogenous, low‐sodium standard oral diet (n = 19)
Number of subjects: 35
Study: 7408673

Group type: EXPERIMENTAL
Intervention: Irrigation treatment with Capmul 8210
Number of subjects: 11
Study: 28916955

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Multiport laparoscopic surgery (MPLS)
Number of subjects: 194
Study: 28802448

Group type: EXPERIMENTAL
Intervention: Four-color design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grayscale design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Map background
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radar background
Number of subjects: 0
Study: 25616294

Group type: EXPERIMENTAL
Intervention: High-dose amino acids (3.0 g/kg per day, increasing by 0.5-1.0 g/kg daily, max 4.0 g/kg per day)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Medium-dose amino acids (2.0 g/kg per day, increasing by 1.0 g/kg daily, max 3.7 g/kg per day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Low-dose amino acids (1.0 g/kg per day, increasing by 1.0 g/kg daily, max 3.5 g/kg per day)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: High-dose amino acids (3.0 g/kg per day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Low-dose amino acids (1.0 g/kg per day)
Number of subjects: 86
Study: 23020146

Group type: EXPERIMENTAL
Intervention: Parenting program plus a reading intervention (n = 88)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Nonintervention condition (n = 86)
Number of subjects: 174
Study: 20374582

Group type: EXPERIMENTAL
Intervention: Outpatient microwave endometrial ablation in the postmenstrual phase
Number of subjects: 197

Group type: COMPARATOR
Intervention: Day surgery microwave endometrial ablation after standard drug-based endometrial preparation
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 197
Study: 18414765

Group type: EXPERIMENTAL
Intervention: Monarc transobturator sling
Number of subjects: 155

Group type: COMPARATOR
Intervention: Tension-free vaginal tape
Number of subjects: 155
Study: 16172148

Group type: EXPERIMENTAL
Intervention: Single embryo transfer (SET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Double embryo transfer (DET)
Number of subjects: 0
Study: 14582612

Group type: EXPERIMENTAL
Intervention: Nonlinear coupling during late TILT phase in TILT-positive group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonlinear coupling during late TILT phase in TILT-negative group
Number of subjects: 21
Study: 10712322

Group type: EXPERIMENTAL
Intervention: Chest radiographic screening
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tuberculin skin testing
Number of subjects: 3

Group type: COMPARATOR
Intervention: Mass tuberculin skin testing
Number of subjects: 3
Study: 9403421

Group type: EXPERIMENTAL
Intervention: Ottawa Knee Rule implementation
Number of subjects: 3907

Group type: COMPARATOR
Intervention: Control group (no Ottawa Knee Rule)
Number of subjects: 3907
Study: 8218757

Group type: EXPERIMENTAL
Intervention: Telenzepine (3 mg p.o.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3304794

Group type: EXPERIMENTAL
Intervention: Erythrocyte sedimentation rate (ESR)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Changes in ESR
Number of subjects: 159
Study: 28868610

Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography (CBCT) imaging system (GALILEOS, Sirona Dental Systems, Bensheim, Germany) at 15‐30 mA and 98 kV
Number of subjects: 200
Study: 27102223

Group type: EXPERIMENTAL
Intervention: Intra and extra circumoral exercise (25 min a day, six times per week for 4 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 41
Study: 24344670

Group type: EXPERIMENTAL
Intervention: Quinoa flakes (QF)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Corn flakes (CF)
Number of subjects: 35
Study: 22941315

Group type: EXPERIMENTAL
Intervention: Head eccentricity during touch presentation and response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Head returned to center before reporting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gaze-centered reference frame
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Body-centered reference frame
Number of subjects: 0
Study: 19860567

Group type: EXPERIMENTAL
Intervention: SCTG with Nd:YAG laser (1 W, 10 Hz, 100 mj, 60 s, 1064 nm)
Number of subjects: 17

Group type: COMPARATOR
Intervention: SCTG without Nd:YAG laser (control group)
Number of subjects: 17
Study: 18640464

Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DIO-902 200 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DIO-902 400 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DIO-902 600 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DIO-902 (all doses)
Number of subjects: 36
Study: 16155269

Group type: EXPERIMENTAL
Intervention: Fortified milk with 1000 microg crystalline cobalamin
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Cobalamin capsule with 1000 microg crystalline cobalamin
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo milk
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 112
Study: 12537676

Group type: EXPERIMENTAL
Intervention: Pilocarpine 1% with Clonidine 0.06%
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Pilocarpine 1% with Clonidine 0.125%
Number of subjects: 54

Group type: COMPARATOR
Intervention: Timolol 0.25%
Number of subjects: 54
Study: 9825270

Group type: EXPERIMENTAL
Intervention: SPA-S-565 (150 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Rifampicin (150 mg)
Number of subjects: 6
Study: 8131705

Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg, taken orally twice a day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Naproxen and Placebo (both groups)
Number of subjects: 28
Study: 2529873

Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin
Number of subjects: 40

Group type: COMPARATOR
Intervention: cefoxitin
Number of subjects: 40
Study: 1105277

Group type: EXPERIMENTAL
Intervention: 1% tetracaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7452705

Group type: EXPERIMENTAL
Intervention: Keller Plan
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 196

Group type: COMPARATOR
Intervention: All other disciplines (Control and Keller Plan)
Number of subjects: 196
Study: 31776364

Group type: EXPERIMENTAL
Intervention: Navigation
Number of subjects: 37

Group type: COMPARATOR
Intervention: Fluoroscopy
Number of subjects: 37
Study: 28087066

Group type: EXPERIMENTAL
Intervention: Gastrografin
Number of subjects: 242

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 242
Study: 26881508

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy (6 fractions per week, 66Gy/33#/5½ weeks)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Concurrent chemoradiation (CCRT) (5 fractions per week, 66Gy/33#/6½ weeks, with intravenous cisplatin 30 mg/m(2) weekly)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy
Number of subjects: 133

Group type: COMPARATOR
Intervention: CCRT
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 133
Study: 24075779

Group type: EXPERIMENTAL
Intervention: Single-agent trastuzumab or lapatinib
Number of subjects: 19
Study: 22134468

Group type: EXPERIMENTAL
Intervention: PR‐STENT
Number of subjects: 18

Group type: COMPARATOR
Intervention: NO‐STENT
Number of subjects: 18
Study: 19101266

Group type: EXPERIMENTAL
Intervention: Left ventricular assisted technique (LVA)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Minimal extracorporeal circulation (MECC)
Number of subjects: 73
Study: 17496418

Group type: EXPERIMENTAL
Intervention: Riopan Gel (800 mg magaldrate)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rennie (680 mg calcium carbonate and 80 mg magnesium carbonate)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (no drug)
Number of subjects: 24
Study: 15374707

Group type: EXPERIMENTAL
Intervention: 17beta‐estradiol (2 mg) + norethisterone acetate (1 mg; E(2)‐NETA)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: raloxifene hCL (60 mg)
Number of subjects: 28
Study: 12135137

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RF‐CA)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (electrophysiologic study)
Number of subjects: 63
Study: 9825188

Group type: EXPERIMENTAL
Intervention: 15 mg moexipril hydrochloride (single oral dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined sequential hormone replacement therapy (HRT) for 25 days
Number of subjects: 0
Study: 7907130

Group type: EXPERIMENTAL
Intervention: Paclitaxel (200 to 420 mg/m2) administered as a 24‐hour intravenous infusion
Number of subjects: 30
Study: 2576423

Group type: COMPARATOR
Intervention: Abrupt Withdrawal (AW) group (n=15) received placebo for 10 nights
Number of subjects: 36

Group type: COMPARATOR
Intervention: Gradual Withdrawal (GW) group (n=16) received temazepam 5 mg for the first 4 nights, 2 mg for the next 4 nights, and placebo for the last 2 nights
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Baseline period for both groups (AW and GW)
Number of subjects: 36
Study: 1089359

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 30971217

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 320
Study: 28374097

Group type: EXPERIMENTAL
Intervention: Additional testing with LightCycler®SeptiFast during intervention period (IP)
Number of subjects: 1416

Group type: COMPARATOR
Intervention: Standard diagnostic workup during control period (CP)
Number of subjects: 1416
Study: 26374430

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training programme (supervised progressive resistance exercise training, balance-training, and walking for 5-7 consecutive days, 20 min sessions twice a day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 35
Study: 23703041

Group type: EXPERIMENTAL
Intervention: Classical music therapy (15-minute sessions, twice a day for three consecutive days)
Number of subjects: 12
Study: 21233083

Group type: EXPERIMENTAL
Intervention: DHA 250 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DHA 500 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: DHA 250 mg/day and DHA 500 mg/day
Number of subjects: 60
Study: 18069063

Group type: EXPERIMENTAL
Intervention: Live high-train low simulated altitude (ALT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Matched control group (CON)
Number of subjects: 9
Study: 17535990

Group type: COMPARATOR
Intervention: No intervention (baseline measurements before trial supplements)
Number of subjects: 381
Study: 15161067

Group type: EXPERIMENTAL
Intervention: Intranasal vaccination with CRM197 alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal vaccination with CRM197 formulated with chitosan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parenteral immunization with conventional diphtheria toxoid vaccine
Number of subjects: 0
Study: 11963647

Group type: EXPERIMENTAL
Intervention: 20 mg ambroxol hydrochloride lozenges
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 218
Study: 9814450

Group type: EXPERIMENTAL
Intervention: Early referral to an endocrinologist
Number of subjects: 70
Study: 7867830

Group type: EXPERIMENTAL
Intervention: Topical acyclovir ointment, 5 times daily for 7 days
Number of subjects: 57

Group type: COMPARATOR
Intervention: Oral acyclovir, 800 mg, 5 times daily for 7 days
Number of subjects: 57
Study: 2760908

Group type: EXPERIMENTAL
Intervention: Borage oil (containing 18:3n‐6)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fish oil (containing 20:5n‐3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 30
Study: 1272683

Group type: EXPERIMENTAL
Intervention: Affective social reinforcement condition ("good-fine")
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Informative social reinforcement condition ("correct-right")
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rule-governed imitation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reinforcement administered on a fixed ratio (FR4) schedule
Number of subjects: 40
Study: 29985719

Group type: EXPERIMENTAL
Intervention: BEMER therapy combined with rehabilitation for 10 consecutive days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham BEMER treatment combined with rehabilitation
Number of subjects: 30
Study: 30971301

Group type: EXPERIMENTAL
Intervention: Definitive concurrent chemoradiotherapy (DCRT) with intensity-modulated radiation therapy (IMRT) at 50 Gy/25 fractions and basic chemotherapy with 5-fluorouracil regimens
Number of subjects: 196

Group type: COMPARATOR
Intervention: Neoadjuvant chemoradiotherapy (NCRT) followed by standard oesophagectomy
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Definitive concurrent chemoradiotherapy (DCRT)
Number of subjects: 196
Study: 28536825

Group type: EXPERIMENTAL
Intervention: Intramuscular clodronate (CLO) 200 mg/day i.m. for 10 days, followed by 200 mg/day i.m. for 6 days after 3 and 6 months, added to usual NSAIDs or analgesic drugs.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual treatment with anti-inflammatory or analgesic drugs (Control Group B).
Number of subjects: 40